TIMPs as multifacial proteins
- PMID: 15036259
- DOI: 10.1016/j.critrevonc.2003.09.008
TIMPs as multifacial proteins
Abstract
Tissue inhibitors of metalloproteinases (TIMPs) are natural inhibitors of matrix metalloproteinases (MMPs) found in most tissues and body fluids. By inhibiting MMPs activities, they participate in tissue remodeling of the extracellular matrix (ECM). The balance between MMPs and TIMPs activities is involved in both normal and pathological events such as wound healing, tissue remodeling, angiogenesis, invasion, tumorigenesis and metastasis. The intracellular signalling controlling both TIMPs and MMPs expression begins to be elucidated and gaining insights into the molecular mechanisms regulated by TIMPs and MMPs could represent a new approach in the development of potential therapeutics. Numerous investigations have pointed out that TIMPs exhibit multifunctional activities distinct from MMP inhibition. In this review, we detailed the multiple activities of TIMPs in vivo and in vitro and we reported their implication in physiological and pathological processes. Further, we documented recent studies of their role in hematopoiesis and we itemized the different signalling pathways they induced.
Similar articles
-
[Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].Dtsch Med Wochenschr. 2004 Sep 17;129(38):1976-80. doi: 10.1055/s-2004-831836. Dtsch Med Wochenschr. 2004. PMID: 15375740 Review. German.
-
The role of matrix metalloproteinases in the oral environment.Acta Odontol Scand. 2007 Feb;65(1):1-13. doi: 10.1080/00016350600963640. Acta Odontol Scand. 2007. PMID: 17354089 Review.
-
Novel functions of TIMPs in cell signaling.Cancer Metastasis Rev. 2006 Mar;25(1):99-113. doi: 10.1007/s10555-006-7893-x. Cancer Metastasis Rev. 2006. PMID: 16680576 Review.
-
Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.Eur J Pharmacol. 2006 Mar 8;533(1-3):133-44. doi: 10.1016/j.ejphar.2005.12.082. Epub 2006 Feb 20. Eur J Pharmacol. 2006. PMID: 16487964 Review.
-
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.Eur J Cell Biol. 1997 Oct;74(2):111-22. Eur J Cell Biol. 1997. PMID: 9352216 Review.
Cited by
-
Analysis of the MMP-dependent and independent functions of tissue inhibitor of metalloproteinase-2 on the invasiveness of breast cancer cells.J Cell Commun Signal. 2012 Jun;6(2):87-95. doi: 10.1007/s12079-011-0157-8. Epub 2012 Jan 8. J Cell Commun Signal. 2012. PMID: 22227894 Free PMC article.
-
miRNAs regulate expression and function of extracellular matrix molecules.Matrix Biol. 2013 Mar 11;32(2):74-85. doi: 10.1016/j.matbio.2012.11.003. Epub 2012 Nov 15. Matrix Biol. 2013. PMID: 23159731 Free PMC article. Review.
-
Dual effect of vitamin D3 on breast cancer-associated fibroblasts.BMC Cancer. 2024 Feb 15;24(1):209. doi: 10.1186/s12885-024-11961-z. BMC Cancer. 2024. PMID: 38360633 Free PMC article.
-
Human Papillomavirus Modulates Matrix Metalloproteinases During Carcinogenesis: Clinical Significance and Role of Viral Oncoproteins.In Vivo. 2022 Nov-Dec;36(6):2531-2541. doi: 10.21873/invivo.12990. Epub 2022 Oct 29. In Vivo. 2022. PMID: 36309355 Free PMC article. Review.
-
TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients.BMC Cancer. 2010 Apr 13;10:139. doi: 10.1186/1471-2407-10-139. BMC Cancer. 2010. PMID: 20388222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources